| Literature DB >> 34995210 |
Liyun Guo1,2, Yajuan Chen3, Huiqin Li1, Fanqian Yin1,4, Mingxia Ge1,4, Li Hu1,5, Meiting Zi1, Zhenghong Qin2, Yonghan He1.
Abstract
Telomere is a unique DNA-protein complex which covers the ends of chromosomes to avoid end fusion and maintain the stability and integrity of chromosomes. Telomere length (TL) shortening has been linked to aging and various age-related diseases in humans. Here we recruited a total of 1031 Chinese individuals aged between 12 and 111 years, including 108 families with parents and their offspring. DNA was extracted from peripheral white blood cells and TL was measured by quantitative PCR (qPCR). We explored the associations of TL with age, gender and clinical variables, and tested the parental effects on TL variation. First, we found that TL was shortened with age, however, TL was better maintained in females than males. Second, there was a robust association of TL between mother and offspring, but not between father and their offspring. In addition, TL was inversely associated with visceral fat index in females, and positively associated with apolipoprotein A levels. Knockdown of the key genes for lipid metabolism (PNPLA2 and CPT1) shortened the TL in HepG2 cells. These findings indicate that TL is maternally inherited, and impairment of lipid metabolism may contribute to the TL shortening in the Chinese population.Entities:
Keywords: heredity; lipid metabolism; telomere length; visceral fat
Mesh:
Year: 2022 PMID: 34995210 PMCID: PMC8791204 DOI: 10.18632/aging.203810
Source DB: PubMed Journal: Aging (Albany NY) ISSN: 1945-4589 Impact factor: 5.682
General clinical characteristics of the participants.
|
| |||||||||||||
|
|
|
|
|
|
|
| |||||||
| N | Mean(±SD) | N | Mean(±SD) | N | Mean(±SD) | N | Mean(±SD) | N | Mean(±SD) | N | Mean(±SD) | ||
| Height (cm) | 30 | 154.8(±5.9) | 53 | 150.6(±27.7) | 77 | 153.1(±6.9) | 35 | 153.7(±9.2) | 187 | 144.1(±14.0) | 12 | 143.8(±8.3) | 0.000 |
| Weight (kg) | 30 | 57.2(±11.0) | 53 | 57.2(±11.2) | 75 | 54.1(±9.3) | 35 | 53.5(±11.2) | 188 | 40.6(±9.6) | 12 | 41.0(±9.0) | 0.000 |
| Glu (mmol/L) | 46 | 6.17(±1.69) | 81 | 6.85(±2.41) | 100 | 6.68(±1.72) | 46 | 6.92(±1.87) | 286 | 7.57(±2.48) | 69 | 6.08(±1.29) | 0.000 |
| SBP (mmHg) | 63 | 126(±20) | 123 | 137(±21) | 147 | 139(±20) | 54 | 145(±22) | 366 | 144(±25) | 109 | 145(±22) | 0.000 |
| DBP (mmHg) | 63 | 83(±13) | 123 | 89(±13) | 147 | 88(±13) | 54 | 91(±15) | 366 | 82(±15) | 109 | 81(±14) | 0.000 |
| TC (mmol/L) | 67 | 5.04(±1.47) | 125 | 5.47(±1.74) | 149 | 5.69(±2.19) | 49 | 5.98(±1.23) | 417 | 5.05(±1.30) | 108 | 4.71(±1.57) | 0.000 |
| TG (mmol/L) | 73 | 1.77(±1.16) | 135 | 2.38(±2.00) | 166 | 2.15(±1.50) | 51 | 2.16(±2.02) | 417 | 1.61(±1.08) | 108 | 1.64(±1.07) | 0.000 |
| HDL (mmol/L) | 73 | 1.49(±0.40) | 136 | 1.53(±0.40) | 168 | 1.68(±1.49) | 51 | 1.42(±0.35) | 417 | 1.47(±0.36) | 108 | 1.50(±0.47) | 0.08 |
| LDL (mmol/L) | 73 | 3.22(±0.93) | 136 | 3.54(±1.11) | 167 | 3.44(±1.01) | 53 | 3.84(±0.94) | 416 | 3.21(±0.91) | 108 | 2.86(±0.97) | 0.000 |
| ALT (U/L) | 40 | 21.4(±13.6) | 75 | 24.7(±20.9) | 114 | 22.0(±11.3) | 46 | 23.5(±13.0) | 256 | 12.2(±8.4) | 68 | 20.5(±8.4) | 0.000 |
| AST (U/L) | 40 | 24.8(±9.41) | 76 | 29.6(±13.9) | 111 | 28.5(±8.92) | 45 | 29.0(±10.0) | 254 | 25.8(±9.45) | 68 | 32.3(±10.6) | 0.000 |
| ALP (U/L) | 30 | 60.9(±45.9) | 52 | 62.2(±24.4) | 75 | 74.8(±23.0) | 33 | 73.0(±20.6) | 193 | 71.9(±31.5) | 13 | 78.3(±22.2) | 0.083 |
| TB (μmol/L) | 40 | 10.2(±5.9) | 76 | 11.0(±4.4) | 114 | 10.8(±4.9) | 46 | 10.6(±4.3) | 258 | 11.1(±4.2) | 69 | 9.4(±4.6) | 0.222 |
| Cre (μmol/L) | 40 | 59.6(±14.0) | 76 | 69.2(±19.5) | 115 | 72.6(±19.4) | 47 | 77.7(±19.2) | 258 | 83.3(±26.1) | 69 | 90.0(±26.3) | 0.000 |
| UA (μmol/L) | 33 | 304(±83) | 65 | 322(±93) | 95 | 347(±92) | 44 | 362(±90) | 197 | 362(±94) | 69 | 330(±86) | 0.000 |
| BMI (kg/m2) | 30 | 23.8(±3.9) | 53 | 23.9(±3.6) | 76 | 23.0(±3.4) | 35 | 22.2(±3.5) | 187 | 19.2(±3.6) | 12 | 19.7(±3.5) | 0.000 |
| BMR (kJm-2h-1) | 29 | 1160(±138) | 53 | 1168(±242) | 76 | 1112(±191) | 35 | 1099(±223) | 187 | 835(±182) | 12 | 864(±146) | 0.000 |
| BFR (%) | 30 | 29.9(±8.9) | 52 | 28.0(±9.6) | 76 | 27.8(±8.4) | 35 | 26.1(±7.1) | 187 | 24.8(±9.4) | 12 | 22.4(±10.6) | 0.006 |
| PBW (%) | 29 | 51.4(±5.9) | 53 | 52.5(±5.5) | 76 | 51.8(±4.8) | 35 | 51.7(±6.3) | 187 | 48.1(±2.9) | 12 | 54.2(±10.4) | 0.000 |
| VFI (kg/m2) | 29 | 5.28(±3.00) | 52 | 7.07(±3.54) | 76 | 7.30(±3.40) | 34 | 8.39(±4.37) | 187 | 8.53(±3.81) | 12 | 6.96(±2.64) | 0.000 |
| BOM (kg) | 30 | 2.26(±0.31) | 53 | 2.32(±0.37) | 76 | 2.11(±0.38) | 35 | 2.11(±0.51) | 187 | 1.45(±0.49) | 12 | 1.56(±0.44) | 0.000 |
Abbreviations: Glu, blood glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; ALT, alanine transaminase; AST, aspartate transaminase; ALP, alkaline phosphatase; TB, total bilirubin; Cre, creatinine; UA, uric acid; BMI, body mass index; BMR, basic metabolism rate; BFR, body fat rate; PBW, percent body water; VFI, visceral fat index; BOM, bone mass.
Figure 1Associations of telomere length (TL) with age. (A, B) Scatter plot of TL with age in female (n=720) and male subjects (n=289), respectively. (C, D) The distribution of TL in female and male at different age groups. f, female; m, male.
Age-adjusted intrafamilial correlations of telomere length (TL).
|
|
|
|
|
|
| 76 | 0.44 | 0.0001 |
| Mother-daughter | 19 | 0.62 | 0.01 |
| Mother-son | 57 | 0.35 | 0.01 |
|
| 32 | 0.23 | 0.36 |
| Father-daughter | 10 | 0.41 | 0.36 |
| Father-son | 22 | 0.19 | 0.46 |
Correlations between telomere length and indicators involved.
|
|
|
|
|
|
| |
| height(kg) | 0.02 | 0.71 | 0.04 | 0.51 | -0.02 | 0.885 |
| BMI(kg/m2) | -0.08 | 0.096 | -0.07 | 0.222 | -0.12 | 0.280 |
| BM kJ/(m2·h) | -0.06 | 0.23 | -0.08 | 0.188 | -0.01 | 0.902 |
| BFR(%) | -0.09 | 0.09 | -0.07 | 0.241 | -0.16 | 0.137 |
|
| 0.15 | 0.004 | 0.14 |
| 0.17 | 0.110 |
| -0.18 | 0.000 | -0.21 |
| -0.10 | 0.350 | |
| BOM(kg) | -0.02 | 0.63 | -0.04 | 0.530 | 0.06 | 0.613 |
| weight(kg) | -0.08 | 0.14 | -0.08 | 0.184 | -0.05 | 0.658 |
| Glu(mmol/L) | 0.01 | 0.77 | -0.01 | 0.789 | 0.13 | 0.119 |
| SBP(mmhg) | -0.02 | 0.66 | -0.03 | 0.474 | 0.03 | 0.699 |
| DBP(mmhg) | -0.03 | 0.45 | -0.03 | 0.437 | -0.01 | 0.922 |
| TC(mmol/l) | 0.03 | 0.33 | 0.04 | 0.294 | -0.01 | 0.932 |
| TG(mmol/L) | 0.001 | 0.99 | -0.02 | 0.658 | 0.03 | 0.591 |
| HDL(mmol/L) | -0.04 | 0.22 | -0.03 | 0.455 | -0.12 | 0.051 |
| LDL(mmol/L) | 0.05 | 0.16 | 0.07 | 0.06 | -0.04 | 0.558 |
| ALT(U/L) | -0.05 | 0.27 | -0.07 | 0.118 | 0.03 | 0.753 |
|
| -0.08 | 0.07 | -0.10 |
| -0.02 | 0.770 |
| ALP(U/L) | 0.04 | 0.411 | 0.06 | 0.287 | -0.04 | 0.694 |
| TB(μmol/L) | 0.07 | 0.098 | 0.07 | 0.123 | 0.05 | 0.575 |
| Cre(μmol/L) | -0.03 | 0.47 | -0.03 | 0.597 | -0.06 | 0.476 |
| UA(μmol/L) | -0.03 | 0.56 | -0.04 | 0.46 | -0.003 | 0.972 |
Parameters and values in bold represent statistically significant correlation.
Abbreviations: all, all samples; f, female; m, male; BMI, body mass index; BMR, basic metabolism rate; BFR, body fat rate; PBW, percent body water; VFI, visceral fat index; BOM, bone mass; Glu, blood glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; ALT, alanine transaminase; AST, aspartate transaminase; ALP, alkaline phosphatase; TB, total bilirubin; Cre, creatinine; UA, uric acid.
Figure 2Correlation between telomere length (TL) and visceral fat (n=394) (A), ApoA2 (n=144) (B), and ApoA1 levels (n=144) (C).
Figure 3Knockdown of genes for lipid metabolism shortened telomere length (TL) in HepG2 cells. PNPLA2 and CPT1 genes were knocked down by short-hairpin RNA (shRNA) in HepG2 cells. (A) Efficiency of gene knockdown by short-hairpin RNA (shRNA) was evaluated by qPCR. (B) Oil red O staining in HepG2 cells after PNPLA2 and CPT1 knockdown by shRNA. (C) TL was determined by qPCR in HepG2 cells. Data were expression as mean±SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.